• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立具有器官侵犯和纤维化的胃癌腹膜播散异种移植小鼠模型。

Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.

作者信息

Okazaki Mitsuyoshi, Fushida Sachio, Harada Shinichi, Tsukada Tomoya, Kinoshita Jun, Oyama Katsunobu, Miyashita Tomoharu, Ninomiya Itasu, Ohta Tetsuo

机构信息

Department of Gastroenterological Surgery, Division of Cancer medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Ishikawa, Japan.

Center for Biomedical Research and Education, School of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Ishikawa, Japan.

出版信息

BMC Cancer. 2017 Jan 5;17(1):23. doi: 10.1186/s12885-016-2991-9.

DOI:10.1186/s12885-016-2991-9
PMID:28056854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5217597/
Abstract

BACKGROUND

The clinical prognosis of gastric cancer with peritoneal dissemination is poor because of its chemoresistance and rich fibrosis. While several gastric cancer cell lines have been used to establish models of peritoneal dissemination by intraperitoneal injection, most peritoneal tumors that form adopt a medullary pattern in microscopic appearance. This histological finding for the model differs from that in the clinical situation. This study was performed to demonstrate the contribution of human peritoneal mesothelial cells (HPMCs) to fibrotic tumor formation and to establish a new xenograft model with high potential for peritoneal dissemination with organ invasion and extensive fibrosis.

METHODS

We established four types of xenograft model: i) intraperitoneal injection of MKN45-P cells alone (control group), ii) injection of MKN45-P cells co-cultured with HPMCs (co-cultured group), iii) scratching the parietal peritoneum (parietal group), and iv) scratching the visceral peritoneum (visceral group) with a cotton swab before injection of co-cultured cells. Fibrosis, α-smooth muscle actin expression, and organ invasion by tumor cells were all assessed by immunohistochemical examination.

RESULTS

All mice developed abdominal swelling with peritoneal tumors and bloody ascites. Tumors of the control and co-cultured groups were not invasive or fibrotic. Contrastingly, tumors of the scratch groups exhibited rich stromal fibrosis and possessed increased α-smooth muscle actin (α-SMA) expression. In particular, the visceral group showed edematous and spreading tumors invading the intestinal wall.

CONCLUSION

We established a model of peritoneal dissemination with organ invasion and stromal fibrosis. Formation of peritoneal dissemination required a favorable environment for cell adhesion, invasion, and growth. This model may be useful for analyzing the pathogenesis and treatment of peritoneal dissemination of gastric cancer.

摘要

背景

伴有腹膜播散的胃癌临床预后较差,因其具有化学抗性且纤维化严重。虽然已有几种胃癌细胞系通过腹腔注射用于建立腹膜播散模型,但大多数形成的腹膜肿瘤在显微镜下呈现髓样模式。该模型的这一组织学发现与临床情况不同。本研究旨在证明人腹膜间皮细胞(HPMC)对纤维化肿瘤形成的作用,并建立一种具有高腹膜播散潜能、伴有器官侵犯和广泛纤维化的新型异种移植模型。

方法

我们建立了四种类型的异种移植模型:i)单独腹腔注射MKN45-P细胞(对照组),ii)注射与HPMC共培养的MKN45-P细胞(共培养组),iii)刮擦壁腹膜(壁腹膜组),以及iv)在注射共培养细胞前用棉签刮擦脏腹膜(脏腹膜组)。通过免疫组织化学检查评估纤维化、α-平滑肌肌动蛋白表达以及肿瘤细胞的器官侵犯情况。

结果

所有小鼠均出现腹部肿胀、腹膜肿瘤和血性腹水。对照组和共培养组的肿瘤无侵袭性或纤维化。相反,刮擦组的肿瘤表现出丰富的间质纤维化且α-平滑肌肌动蛋白(α-SMA)表达增加。特别是,脏腹膜组显示出水肿性且蔓延的肿瘤侵犯肠壁。

结论

我们建立了一种伴有器官侵犯和间质纤维化的腹膜播散模型。腹膜播散的形成需要有利于细胞黏附、侵袭和生长的环境。该模型可能有助于分析胃癌腹膜播散的发病机制和治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/21260ec894b7/12885_2016_2991_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/41fe803b3103/12885_2016_2991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/9cffa9cdff04/12885_2016_2991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/ef9b648a0aaf/12885_2016_2991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/21260ec894b7/12885_2016_2991_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/41fe803b3103/12885_2016_2991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/9cffa9cdff04/12885_2016_2991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/ef9b648a0aaf/12885_2016_2991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea8/5217597/21260ec894b7/12885_2016_2991_Fig4_HTML.jpg

相似文献

1
Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.建立具有器官侵犯和纤维化的胃癌腹膜播散异种移植小鼠模型。
BMC Cancer. 2017 Jan 5;17(1):23. doi: 10.1186/s12885-016-2991-9.
2
Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.肥大细胞来源的白细胞介素-17A 促进伴有腹膜转移的胃癌纤维化。
Gastric Cancer. 2021 Jan;24(1):31-44. doi: 10.1007/s10120-020-01092-2. Epub 2020 Jun 2.
3
Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.人腹膜间皮细胞在胃癌进展、纤维化和控制中的重要性:曲尼司特抑制生长和纤维化。
Gastric Cancer. 2018 Jan;21(1):55-67. doi: 10.1007/s10120-017-0726-5. Epub 2017 May 24.
4
The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.人腹膜间皮细胞在胃癌纤维化和进展中的作用。
Int J Oncol. 2012 Aug;41(2):476-82. doi: 10.3892/ijo.2012.1490. Epub 2012 May 18.
5
SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.鞘氨醇激酶 1 诱导的腹膜间皮细胞自噬增强胃癌腹膜转移。
Cancer Med. 2019 Apr;8(4):1731-1743. doi: 10.1002/cam4.2041. Epub 2019 Feb 21.
6
Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.转化生长因子-β1信号通路阻断可减轻胃癌细胞诱导的腹膜间皮细胞纤维化,并在体外和体内减轻腹膜播散。
Tumour Biol. 2014 Apr;35(4):3575-83. doi: 10.1007/s13277-013-1472-x. Epub 2013 Dec 18.
7
HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.缺氧诱导因子-1α 是通过自然转移途径在硬癌型胃癌中发生腹膜扩散的关键因素。
Int J Oncol. 2013 Nov;43(5):1431-40. doi: 10.3892/ijo.2013.2068. Epub 2013 Aug 21.
8
Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.P17肽阻断转化生长因子-β1可减轻胃癌细胞诱导的腹膜纤维化,并在体外和体内预防腹膜播散。
Biomed Pharmacother. 2017 Apr;88:27-33. doi: 10.1016/j.biopha.2017.01.039. Epub 2017 Jan 13.
9
A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.一种新型转化生长因子β受体激酶抑制剂A-77可预防硬癌型胃癌的腹膜播散。
Clin Cancer Res. 2008 May 1;14(9):2850-60. doi: 10.1158/1078-0432.CCR-07-1634.
10
Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.硬癌胃癌细胞诱导的腹膜纤维化可能充当腹膜播散的“土壤”。
Cancer. 1996 Apr 15;77(8 Suppl):1668-75. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1668::AID-CNCR37>3.0.CO;2-W.

引用本文的文献

1
Cell Biology of Cancer Peritoneal Metastasis: Multiclonal Seeding and Peritoneal Tumor Microenvironment.癌症腹膜转移的细胞生物学:多克隆播种与腹膜肿瘤微环境
Cancer Sci. 2025 May;116(5):1171-1180. doi: 10.1111/cas.70021. Epub 2025 Feb 13.
2
Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study.雷莫西尤单抗既往使用对纳武利尤单抗作为胃癌三线治疗方案疗效的临床意义:一项多中心回顾性研究
Drugs Real World Outcomes. 2024 Dec;11(4):557-564. doi: 10.1007/s40801-024-00460-z. Epub 2024 Oct 19.
3
Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis.

本文引用的文献

1
Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.蛋白结合多糖K通过抑制转化生长因子-β信号通路抑制胃癌中的肿瘤纤维化。
Oncol Rep. 2015 Feb;33(2):553-8. doi: 10.3892/or.2014.3636. Epub 2014 Nov 28.
2
The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.血管紧张素 II 型 1 型受体阻滞剂坎地沙坦可抑制胃癌的增殖和纤维化。
Cancer Lett. 2014 Dec 1;355(1):46-53. doi: 10.1016/j.canlet.2014.09.019. Epub 2014 Sep 16.
3
Treatment of gastric cancer.
半乳糖凝集素-1 通过腹膜纤维化促进胃癌腹膜转移。
BMC Cancer. 2023 Jun 17;23(1):559. doi: 10.1186/s12885-023-11047-2.
4
BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.BGN/FAP/STAT3 正反馈环路介导的肿瘤细胞与间皮细胞的相互作用促进胃癌腹膜转移。
Int J Biol Sci. 2023 Jan 1;19(2):465-483. doi: 10.7150/ijbs.72218. eCollection 2023.
5
Magnetic Compression of Tumor Spheroids Increases Cell Proliferation In Vitro and Cancer Progression In Vivo.肿瘤球体的磁性压缩增加体外细胞增殖和体内癌症进展。
Cancers (Basel). 2022 Jan 12;14(2):366. doi: 10.3390/cancers14020366.
6
Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.肿瘤内大量纤维化可阻止淋巴细胞浸润结直肠癌腹膜转移。
PLoS One. 2021 Jul 22;16(7):e0255049. doi: 10.1371/journal.pone.0255049. eCollection 2021.
7
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications.用于临床应用开发的腹膜癌病小鼠模型。
Cancers (Basel). 2021 Feb 25;13(5):963. doi: 10.3390/cancers13050963.
8
Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.肥大细胞来源的白细胞介素-17A 促进伴有腹膜转移的胃癌纤维化。
Gastric Cancer. 2021 Jan;24(1):31-44. doi: 10.1007/s10120-020-01092-2. Epub 2020 Jun 2.
9
Cryopreserved human skin allografts promote angiogenesis and dermal regeneration in a murine model.冷冻保存的异体人皮肤移植物促进了小鼠模型中的血管生成和真皮再生。
Int Wound J. 2020 Aug;17(4):925-936. doi: 10.1111/iwj.13349. Epub 2020 Mar 30.
10
Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.应用非侵入性生物发光成像技术比较结直肠癌小鼠模型中腹膜转移的种植部位。
PLoS One. 2019 Jul 31;14(7):e0220360. doi: 10.1371/journal.pone.0220360. eCollection 2019.
胃癌的治疗。
World J Gastroenterol. 2014 Feb 21;20(7):1635-49. doi: 10.3748/wjg.v20.i7.1635.
4
Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106).随机 III 期研究:氟尿嘧啶持续输注与甲氨蝶呤和氟尿嘧啶序贯治疗在伴有腹膜转移的晚期胃癌中的疗效比较(JCOG0106)。
Jpn J Clin Oncol. 2013 Oct;43(10):972-80. doi: 10.1093/jjco/hyt114. Epub 2013 Sep 7.
5
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.一项评估腹腔内多西紫杉醇联合 S-1 治疗腹膜转移胃癌患者的 I/II 期研究。
Cancer Chemother Pharmacol. 2013 May;71(5):1265-72. doi: 10.1007/s00280-013-2122-0. Epub 2013 Feb 20.
6
Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.间皮细胞在硬癌胃癌微环境下向成纤维细胞样细胞分化,并在体外和体内促进腹膜癌转移。
Mol Cell Biochem. 2013 May;377(1-2):177-85. doi: 10.1007/s11010-013-1583-0. Epub 2013 Feb 8.
7
Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.建立腹膜转移异种移植小鼠模型评估实验性胃癌的生存结局。
J Surg Res. 2013 Jun 15;182(2):227-34. doi: 10.1016/j.jss.2012.10.052. Epub 2012 Nov 15.
8
The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.人腹膜间皮细胞在胃癌纤维化和进展中的作用。
Int J Oncol. 2012 Aug;41(2):476-82. doi: 10.3892/ijo.2012.1490. Epub 2012 May 18.
9
Mechanisms of the formation of the peritoneal dissemination in gastric cancer.胃癌腹膜播散的形成机制
Int J Oncol. 1996 Apr;8(4):795-802. doi: 10.3892/ijo.8.4.795.
10
Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro.人腹膜间皮细胞在 TGF-ß1 刺激下体外向肌成纤维细胞的转化。
Int J Mol Med. 2011 Feb;27(2):187-93. doi: 10.3892/ijmm.2010.574. Epub 2010 Dec 6.